Author:
Lee Seongju,Lee Seung-Eun,Han Jae-Ik,Lee Sang Chul,Jeon Yubyeol
Abstract
Abstract
Background
Fluid therapy in veterinary medicine is pivotal for treating various conditions in pigs; however, standard solutions, such as Hartmann’s solution, may not optimally align with pig physiology. This study explored the development and efficacy of a customized fluid therapy tailored to the ionic concentrations of pig blood, aiming to enhance treatment outcomes and safety in both healthy and diseased pigs.
Results
The study involved two experiments: the first to assess the safety and stability of customized fluids in healthy pigs, and the second to evaluate the efficacy in pigs with clinical symptoms of dehydration. In healthy pigs, the administration of customized fluids showed no adverse effects, with slight alterations observed in pO2, hematocrit, and glucose levels in some groups. In symptomatic pigs, the customized fluid group did not show any improvement in clinical symptoms, with no significant changes in blood chemistry or metabolite levels compared to controls. The customized fluid group showed a mild increase in some values after administration, yet within normal physiological ranges. The study reported no significant improvements in clinical or dehydration status, attributing the observed variations in blood test results to the limited sample size and anaesthesia effects rather than fluid characteristics.
Conclusions
Customized fluid therapy, tailored to mimic the ionic concentrations of pig blood, appears to be a safe and potentially more effective alternative to conventional solutions such as Hartmann’s solution for treating pigs under various health conditions. Further research with larger sample sizes and controlled conditions is recommended to validate these findings and to explore the full potential of customized fluid therapy in veterinary practice.
Funder
Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry
National Institute of Wildlife Disease Control and Prevention
Publisher
Springer Science and Business Media LLC
Reference49 articles.
1. Mazzaferro E, Powell LL. Fluid therapy for the emergent small animal patient: crystalloids, colloids, and albumin products. Veterinary Clinics: Small Anim Pract. 2013;43(4):721–34.
2. Bywater R, Woode G. Oral fluid replacement by a glucose glycine electrolyte formulation in E coli and rotavirus diarrhoea in pigs. Vet Rec. 1980;106(4):75–8.
3. Drolet R, Morin M, Fontaine M. Fluid therapy trials in neonatal piglets infected with transmissible gastroenteritis virus. Can J Comp Med. 1985;49(4):357.
4. Reshma A, Gowda A, Aswathanarayanappa V. Dystocia due to primary uterine inertia in a primiparous sow: a case report. J Ent Zoo Stud. 2020;8(3):277–8.
5. Hiltebrand LB, Kimberger O, Arnberger M, Brandt S, Kurz A, Sigurdsson GH. Crystalloids versus colloids for goal-directed fluid therapy in major surgery. Crit Care. 2009;13(2):1–13.